The collaboration between biotech company Klothea Bio and Healthy Longevity Clinic leverages a proprietary mRNA platform to upregulate endogenous Klotho, an anti-aging protein. By delivering lipid-encapsulated mRNA instructions, they activate the body’s protein synthesis pathways. The approach aims to counteract age-associated inflammation, cognitive decline, and immune deterioration in adults.
Key points
mRNA-based Klotho delivery via lipid nanoparticles upregulates anti-aging protein expression.
Collaboration recognized as Top 40 semifinalist in the $101 million XPRIZE Healthspan milestone competition.
Preclinical data suggest improved cognition, reduced inflammation, and enhanced immune function in aging models.
Why it matters:
Elevating Klotho via mRNA could revolutionize aging therapeutics by restoring cellular homeostasis and delaying multiple age-related disorders.
Q&A
What is Klotho protein?
How do mRNA therapies work?
What is the XPRIZE Healthspan competition?
Why are lipid nanoparticles used for delivery?
Read full article
Academy
Klotho Protein
Definition and Function: Klotho is a transmembrane and secreted protein initially discovered for its role in phosphate and calcium regulation. It functions as a co-receptor for fibroblast growth factors and modulates signaling pathways involved in metabolism, oxidative stress resistance, and cellular senescence. Secreted Klotho acts as a circulating hormone that influences distant tissues, providing systemic protection against age-associated decline.
Role in Aging: Declining Klotho levels correlate with multiple age-related disorders, including cognitive impairment, kidney disease, osteoporosis, and cardiovascular dysfunction. Experimental models overexpressing Klotho exhibit extended lifespan, improved cognitive performance, reduced inflammation, and enhanced tissue regeneration. This makes Klotho a prime target for therapeutic strategies aimed at delaying the onset of aging phenotypes.
mRNA-Based Therapies for Klotho Elevation
Principles of mRNA Therapeutics: Messenger RNA (mRNA) therapies deliver synthetic strands of mRNA encoding a therapeutic protein directly into cells. Once inside the cytoplasm, ribosomes translate the mRNA into functional protein. This approach avoids direct manipulation of the genome and allows transient, controlled expression.
Lipid Nanoparticle (LNP) Delivery: LNPs are vital for protecting mRNA from degradation and facilitating cellular uptake. They are composed of ionizable lipids, cholesterol, helper phospholipids, and polyethylene glycol (PEG)-lipids. The ionizable lipids neutralize in the acidic endosome environment to promote endosomal escape, releasing mRNA into the cytosol.
Advantages for Klotho Therapy: mRNA-based Klotho supplementation enables precise dosing and temporal control of protein expression. Compared to recombinant protein administration, mRNA requires lower manufacturing complexity and can achieve sustained therapeutic levels. The platform’s adaptability allows rapid sequence updates and optimization for tissue targeting.
Clinical Applications and Future Directions
Potential Indications: Elevating endogenous Klotho may address neurodegenerative diseases (e.g., Alzheimer’s), muscle wasting (sarcopenia), immunosenescence, and chronic kidney disease. Restored Klotho signaling can modulate calcium-phosphate balance, reduce pro-inflammatory cytokines, and improve endothelial function.
Ongoing Development: Collaborations like Klothea Bio and Healthy Longevity Clinic are advancing mRNA Klotho therapies through preclinical validation and early-phase human trials. Milestone recognition in innovation competitions accelerates funding and regulatory support. Future research will refine dosing schedules, delivery routes, and combination approaches with other longevity modalities.
Implications for Longevity Science: mRNA-driven Klotho modulation exemplifies next-generation aging interventions that harness molecular biology advances. By targeting a central regulator of aging, this strategy holds promise for multi-system rejuvenation and establishing new paradigms in preventive geriatric medicine.
